{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T10:54:32Z","timestamp":1794308072669,"version":"4.9.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,6,11]],"date-time":"2020-06-11T00:00:00Z","timestamp":1591833600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,6,11]],"date-time":"2020-06-11T00:00:00Z","timestamp":1591833600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1208\/s12249-020-01711-2","type":"journal-article","created":{"date-parts":[[2020,6,11]],"date-time":"2020-06-11T20:02:52Z","timestamp":1591905772000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Enhanced Oral Bioavailability of Felodipine from Solid Lipid Nanoparticles Prepared Through Effervescent Dispersion Technique"],"prefix":"10.1208","volume":"21","author":[{"given":"Yingmeng","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenglin","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Pi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuntian","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumeng","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,11]]},"reference":[{"key":"1711_CR1","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.addr.2019.06.006","volume":"143","author":"Y Lu","year":"2019","unstructured":"Lu Y, Lv Y, Li T. Hybrid drug nanocrystals. Adv Drug Deliv Rev. 2019;143:115\u201333.","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"1711_CR2","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.apsb.2019.01.009","volume":"9","author":"W Wu","year":"2019","unstructured":"Wu W, Lu Y, Qi J. Editorial: persistent endeavors for the enhancement of dissolution and oral bioavailability. Acta Pharm Sin B. 2019;9(1):2\u20133.","journal-title":"Acta Pharm Sin B"},{"issue":"19","key":"1711_CR3","first-page":"30378","volume":"S1359\u20136446","author":"W Huang","year":"2019","unstructured":"Huang W, Wu X, Qi J, Zhu Q, Wu W, Lu Y, et al. Ionic liquids: green and tailor-made solvents in drug delivery. Drug Discov Today. 2019;S1359\u20136446(19):30378\u20132.","journal-title":"Drug Discov Today"},{"issue":"1","key":"1711_CR4","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.apsb.2018.05.004","volume":"9","author":"X Ren","year":"2019","unstructured":"Ren X, Qi J, Wu W, Yin Z, Li T, Lu Y. Development of carrier-free nanocrystals of poorly water-soluble drugs by exploring metastable zone of nucleation. Acta Pharm Sin B. 2019;9(1):118\u201327.","journal-title":"Acta Pharm Sin B"},{"key":"1711_CR5","doi-asserted-by":"crossref","unstructured":"Liu D, Wan B, Qi J, Dong X, Zhao W, Wu W, et al. Permeation into but not across the cornea: bioimaging of intact nanoemulsions and nanosuspensions using aggregation-caused quenching probes. Chinese Chem Lett. 2018;29(12):1834\u2013183 8.","DOI":"10.1016\/j.cclet.2018.11.015"},{"issue":"2","key":"1711_CR6","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s13204-012-0188-3","volume":"4","author":"BP Sahu","year":"2014","unstructured":"Sahu BP, Das MK. Nanosuspension for enhancement of oral bioavailability of felodipine. Appl Nanosci. 2014;4(2):189\u201397.","journal-title":"Appl Nanosci"},{"issue":"6","key":"1711_CR7","first-page":"2039","volume":"6","author":"PK Patel","year":"2017","unstructured":"Patel PK. Solid dispersion as a formulation strategy: a mini review. J Chem and Lifesci. 2017;6(6):2039\u201345.","journal-title":"J Chem and Lifesci"},{"key":"1711_CR8","doi-asserted-by":"crossref","first-page":"105159","DOI":"10.1016\/j.ejps.2019.105159","volume":"142","author":"D Parashar","year":"2019","unstructured":"Parashar D, Rajendran V, Shukla R. Lipid-based nanocarriers for delivery of small interfering RNA for therapeutic use. Eur J Pharm Sci. 2019;142:105159.","journal-title":"Eur J Pharm Sci"},{"key":"1711_CR9","doi-asserted-by":"crossref","first-page":"352","DOI":"10.3109\/10717541003762839","volume":"17","author":"C Liu","year":"2010","unstructured":"Liu C, Liu D, Bai F. In vitro and in vivo studies of lipid-based nanocarriers for oral N3-o-toluyl-fluorouracil delivery. Drug Deliv. 2010;17:352\u201363.","journal-title":"Drug Deliv"},{"key":"1711_CR10","first-page":"102048","volume":"7","author":"A Rehman","year":"2019","unstructured":"Rehman A, Tong Q, Jafari SM, Assadpour E, Shehzad Q, Aadil RM, et al. Carotenoid-loaded nanocarriers: a comprehensive review. Adv Colloid Interf Sci. 2019;7:102048.","journal-title":"Adv Colloid Interf Sci"},{"issue":"3","key":"1711_CR11","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nrd2197","volume":"6","author":"CJ Porter","year":"2007","unstructured":"Porter CJ, Trevaskis NL, Charman WN. Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs. Nat Rev Drug Discov. 2007;6(3):231\u201348.","journal-title":"Nat Rev Drug Discov"},{"key":"1711_CR12","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.drudis.2016.09.024","volume":"22","author":"J Qi","year":"2017","unstructured":"Qi J, Zhuang J, Lu Y, Dong X, Zhao W, Wu W. In vivo fate of lipid-based nanoparticles. Drug Discov Today. 2017;22:166\u201372.","journal-title":"Drug Discov Today"},{"issue":"13","key":"1711_CR13","doi-asserted-by":"crossref","first-page":"7024","DOI":"10.1039\/C5NR07474F","volume":"8","author":"X Hu","year":"2016","unstructured":"Hu X, Fan W, Yu Z, Lu Y, Qi J, Zhang J, et al. Evidence does not support absorption of intact solid lipid nanoparticles via oral delivery. Nanoscale. 2016;8(13):7024\u201335.","journal-title":"Nanoscale."},{"issue":"8","key":"1711_CR14","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1016\/j.nano.2015.06.013","volume":"11","author":"X Hu","year":"2015","unstructured":"Hu X, Zhang J, Yu Z, Xie Y, He H, Qi J, et al. Environment-responsive aza-BODIPY dyes quenching in water as potentialprobes to visualize the in vivo fate of lipid-based nanocarriers. Nanomedicine. 2015;11(8):1939\u201348.","journal-title":"Nanomedicine."},{"issue":"4","key":"1711_CR15","first-page":"2995","volume":"8","author":"UK Gondrala","year":"2015","unstructured":"Gondrala UK, Dudhipala N, Kishan V. Preparation, characterization and in vivo evaluation of felodipine solid-lipid nanoparticles for improved oral bioavailability. Int J Pharm Sci Nanotech. 2015;8(4):2995\u20133002.","journal-title":"Int J Pharm Sci Nanotech"},{"key":"1711_CR16","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ijpharm.2006.11.004","volume":"335","author":"VV Kumar","year":"2007","unstructured":"Kumar VV, Chandrasekar D, Ramakrishna S, Kishan V, Rao YM, Diwan PV. Development and evaluation of nitrendipine loaded solid lipid nanoparticles: influence of wax and glyceride lipids on plasma pharmacokinetics. Int J Pharm. 2007;335:167\u201375.","journal-title":"Int J Pharm"},{"key":"1711_CR17","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.colsurfb.2012.04.027","volume":"97","author":"SS Chalikwar","year":"2012","unstructured":"Chalikwar SS, Belgamwar VS, Talele VR, Surana SJ, Patil MU. Formulation and evaluation of Nimodipine-loaded solid lipid nanoparticles delivered via lymphatic transport system. Colloids Surf B: Biointerfaces. 2012;97:109\u201316.","journal-title":"Colloids Surf B: Biointerfaces"},{"issue":"3","key":"1711_CR18","doi-asserted-by":"crossref","first-page":"216","DOI":"10.4103\/0975-1483.83765","volume":"3","author":"P Ekambaram","year":"2011","unstructured":"Ekambaram P, Abdul HSA. Formulation and evaluation of solid lipid nanoparticles of ramipril. J Young Pharm. 2011;3(3):216\u201320.","journal-title":"J Young Pharm"},{"issue":"3","key":"1711_CR19","first-page":"1483","volume":"1","author":"B Parmar","year":"2011","unstructured":"Parmar B, Mandal S, Petkar KC, Patel LD, Sawant KK. Valsartan loaded solid lipid nanoparticles: development, characterization and in vitro and ex vivo evaluation. Int J Pharm Sci. 2011;1(3):1483\u201390.","journal-title":"Int J Pharm Sci"},{"key":"1711_CR20","doi-asserted-by":"crossref","first-page":"305","DOI":"10.15171\/apb.2015.043","volume":"5","author":"N Naseri","year":"2015","unstructured":"Naseri N, Valizadeh H. Solid lipid nanoparticles and nanostructured lipid carriers: structure, preparation and application. Adv Pharm Bull. 2015;5:305\u201313.","journal-title":"Adv Pharm Bull"},{"issue":"2\u20133","key":"1711_CR21","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0169-409X(01)00105-3","volume":"47","author":"W Mehnert","year":"2001","unstructured":"Mehnert W, M\u00e4der K. Solid lipid nanoparticles production, characterization and applications. Adv Drug Deliv Rev. 2001;47(2\u20133):165\u201396.","journal-title":"Adv Drug Deliv Rev"},{"key":"1711_CR22","unstructured":"Domb AJ. Lipospheres for controlled delivery of substances. United States Patent. 1993, USS 188837."},{"issue":"1","key":"1711_CR23","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/j.2042-7158.2010.01184.x","volume":"63","author":"L Zhao","year":"2011","unstructured":"Zhao L, Ye Y, Li J, Wei Y. Preparation and the in-vivo evaluation of paclitaxel liposomes for lung targeting delivery in dogs. J Pharm Pharmacol. 2011;63(1):80\u20136.","journal-title":"J Pharm Pharmacol"},{"issue":"6","key":"1711_CR24","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1007\/s12272-013-0181-8","volume":"37","author":"Y Wei","year":"2014","unstructured":"Wei Y, Xue Z, Ye Y, Huang Y, Zhao L. Paclitaxel targeting to lungs by way of liposomes prepared by the effervescent dispersion technique. Arch Pharm Res. 2014;37(6):728\u201337.","journal-title":"Arch Pharm Res"},{"issue":"3","key":"1711_CR25","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3109\/10611861003801859","volume":"19","author":"L Zhao","year":"2011","unstructured":"Zhao L, Wei Y, Li W, Liu Y, Wang Y, Zhong X, et al. Solid dispersion and effervescent techniques used to prepare docetaxel liposomes for lung-targeted delivery system: in vitro and in vivo evaluation. J Drug Target. 2011;19(3):171\u20138.","journal-title":"J Drug Target"},{"issue":"1","key":"1711_CR26","first-page":"73","volume":"37","author":"JY Yuan","year":"2018","unstructured":"Yuan JY, Pi C, Huang SQ, Liang J, Feng T, Zhan CL, et al. Development and evaluation of felodipine sustained-release tablets. Lat Am J Pharm. 2018;37(1):73\u20139.","journal-title":"Lat Am J Pharm"},{"issue":"5","key":"1711_CR27","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/BF00878548","volume":"9","author":"WC Little","year":"1995","unstructured":"Little WC, Cheng CP, Elvelin L, Nordlander M. Vascular selective calcium entry blockers in the treatment of cardiovascular disorders: focus on felodipine. Cardiovasc Drugs Ther. 1995;9(5):657\u201363.","journal-title":"Cardiovasc Drugs Ther"},{"issue":"41","key":"1711_CR28","doi-asserted-by":"crossref","first-page":"70752","DOI":"10.18632\/oncotarget.19984","volume":"8","author":"D Li","year":"2017","unstructured":"Li D, Xu S, Wang Y, Li X, Pan J. Pharmacokinetics and drug-drug interaction between enalapril, enalaprilat and felodipine extended release (ER) in healthy subjects. Oncotarget. 2017;8(41):70752\u201360.","journal-title":"Oncotarget."},{"issue":"3","key":"1711_CR29","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s13318-013-0158-5","volume":"39","author":"BP Sahu","year":"2014","unstructured":"Sahu BP, Das MK. Preparation and in vitro\/in vivo evaluation of felodipine nanosuspension. Eur J Drug Metab Pharmacokinet. 2014;39(3):183\u201393.","journal-title":"Eur J Drug Metab Pharmacokinet"},{"issue":"3","key":"1711_CR30","doi-asserted-by":"crossref","first-page":"194","DOI":"10.2174\/1574886310666150514114619","volume":"10","author":"K Navadiya","year":"2015","unstructured":"Navadiya K, Tiwari S. Pharmacology, efficacy and safety of felodipine with a focus on hypertension and angina pectoris. Curr Drug Saf. 2015;10(3):194\u2013201.","journal-title":"Curr Drug Saf"},{"issue":"10","key":"1711_CR31","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.3109\/03639045.2013.819885","volume":"40","author":"SM Sandeep","year":"2014","unstructured":"Sandeep SM, Sridhar V, Puneeth Y, Babu PR, Babu KN. Enhanced oral bioavailability of felodipine by naringenin in Wistar rats and inhibition of P-glycoprotein in everted rat gut sacs in vitro. Drug Dev Ind Pharm. 2014;40(10):1371\u20137.","journal-title":"Drug Dev Ind Pharm"},{"issue":"3","key":"1711_CR32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13346-018-0489-5","volume":"8","author":"M Singh","year":"2018","unstructured":"Singh M, Kanoujia J, Parashar P, Arya M, Tripathi CB, Sinha VR, et al. Assessment of improved buccal permeation and bioavailability of felodipine microemulsion-based cross-linked polycarbophil gel. Drug Deliv Transl Res. 2018;8(3):1\u201311.","journal-title":"Drug Deliv Transl Res"},{"issue":"1","key":"1711_CR33","doi-asserted-by":"crossref","first-page":"E116","DOI":"10.3390\/molecules21010116","volume":"21","author":"RB Rigon","year":"2016","unstructured":"Rigon RB, Fachinetti N, Severino P, Santana MH, Chorilli M. Skin delivery and in vitro biological evaluation of trans-resveratrol-loaded solid lipid nanoparticles for skin disorder therapies. Molecules. 2016;21(1):E116.","journal-title":"Molecules."},{"issue":"Suppl 2","key":"1711_CR34","first-page":"S311","volume":"10","author":"HM Yan","year":"2014","unstructured":"Yan HM, Zhang ZH, Jiang YR, Ding DM, Sun E, Jia XB. An attempt to stabilize tanshinone IIA solid dispersion by the use of ternary systems with nano-CaCO3 and poloxamer 188. Pharmacogn Mag. 2014;10(Suppl 2):S311\u20137.","journal-title":"Pharmacogn Mag"},{"key":"1711_CR35","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ejpb.2016.10.022","volume":"10","author":"N Dudhipala","year":"2017","unstructured":"Dudhipala N, Veerabrahma K. Improved anti-hyperlipidemic activity of rosuvastatin calcium via lipid nanoparticles: pharmacokinetic and pharmacodynamic evaluation. Eur J Pharm Biopharm. 2017;10:47\u201357.","journal-title":"Eur J Pharm Biopharm"},{"issue":"2","key":"1711_CR36","first-page":"624841","volume":"2013","author":"S Bhalla","year":"2013","unstructured":"Bhalla S, Nagpal M. Comparison of various generations of superporous hydrogels based on chitosan-acrylamide and in vitro drug release. ISRN Pharm. 2013;2013(2):624841.","journal-title":"ISRN Pharm"},{"key":"1711_CR37","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.bej.2015.09.022","volume":"105","author":"X Xiao","year":"2016","unstructured":"Xiao X, Zhu WW, Yuan H, Li WW, Li Q, Yu HQ. Biosynthesis of FeS nanoparticles from contaminant degradation in one single system. Biochem Eng J. 2016;105:214\u20139.","journal-title":"Biochem Eng J"},{"issue":"1\u20132","key":"1711_CR38","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ijpharm.2008.03.030","volume":"359","author":"F Wan","year":"2008","unstructured":"Wan F, You J, Sun Y, Zhang XG, Cui FD, Du YZ, et al. Studies on PEG-modified SLNs loading vinorelbine bitartrate (I): preparation and evaluation in vitro. Int J Pharm. 2008;359(1\u20132):104\u201310.","journal-title":"Int J Pharm"},{"issue":"49","key":"1711_CR39","doi-asserted-by":"crossref","first-page":"17432","DOI":"10.1021\/ie402625h","volume":"52","author":"L Ochiuz","year":"2013","unstructured":"Ochiuz L, Popa G, Stoleriu I, Tomoiaga AM, Popa M. Microencapsulation of metoprolol tartrate into chitosan for improved oral administration and patient compliance. Ind Eng Chem Res. 2013;52(49):17432\u201341.","journal-title":"Ind Eng Chem Res"},{"key":"1711_CR40","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1208\/s12249-019-1468-y","volume":"20","author":"AD Pathade","year":"2019","unstructured":"Pathade AD, Kommineni N, Bulbake U. Preparation and comparison of oral bioavailability for different nano-formulations of Olaparib. AAPS PharmSciTech. 2019;20:276.","journal-title":"AAPS PharmSciTech"},{"issue":"2","key":"1711_CR41","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1517\/17425247.2014.945416","volume":"12","author":"T Alam","year":"2015","unstructured":"Alam T, Pandit J, Vohora D, Aqil M, Ali A, Sultana Y. Optimization of nanostructured lipid carriers of lamotrigine for brain delivery: in vitro characterization and in vivo efficacy in epilepsy. Expert Opin Drug Deliv. 2015;12(2):181\u201394.","journal-title":"Expert Opin Drug Deliv"},{"key":"1711_CR42","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.msec.2019.03.060","volume":"100","author":"I Ahmad","year":"2019","unstructured":"Ahmad I, Pandit J, Sultana Y, Mishra AK, Hazari PP, Aqil M. Optimization by design of etoposide loaded solid lipid nanoparticles for ocular delivery: characterization, pharmacokinetic and deposition study. Mater Sci Eng C Mater Biol Appl. 2019;100:959\u201370.","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"key":"1711_CR43","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.ijpharm.2013.08.076","volume":"456","author":"S Soares","year":"2013","unstructured":"Soares S, Fonte P, Costa A. Effect of freeze-drying, cryoprotectants and storage conditions on the stability of secondary structure of insulin-loaded solid lipid nanoparticles. Int J Pharm. 2013;456:370\u201381.","journal-title":"Int J Pharm"},{"issue":"3","key":"1711_CR44","doi-asserted-by":"crossref","first-page":"E25","DOI":"10.3390\/pharmaceutics8030025","volume":"8","author":"SG Ong","year":"2016","unstructured":"Ong SG, Ming LC, Lee KS, Yuen KH. Influence of the encapsulation efficiency and size of liposome on the oral bioavailability of griseofulvin-loaded liposomes. Pharmaceutics. 2016;8(3):E25.","journal-title":"Pharmaceutics"},{"issue":"3","key":"1711_CR45","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1208\/s12249-017-0944-5","volume":"9","author":"SVR Silki","year":"2018","unstructured":"Silki SVR. Enhancement of in vivo efficacy and oral bioavailability of aripiprazole with solid lipid nanoparticles. AAPS Pharm Sci Tech. 2018;9(3):1264\u201373.","journal-title":"AAPS Pharm Sci Tech"},{"issue":"22","key":"1711_CR46","first-page":"3118","volume":"27","author":"C Kai","year":"2016","unstructured":"Kai C, Shou LI, Kai J. Formulation optimization of indomethacin-loading solid lipid nanoparticles by box-Behnken response surface methodology. China Pharmacy. 2016;27(22):3118\u201320.","journal-title":"China Pharmacy"},{"issue":"2","key":"1711_CR47","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.ijpharm.2006.11.057","volume":"336","author":"JB Brubach","year":"2007","unstructured":"Brubach JB, Jannin V, Mahler B. Structural and thermal characterization of glyceryl behenate by X-ray diffraction coupled to differential calorimetry and infrared spectroscopy. Int J Pharm. 2007;336(2):248\u201356.","journal-title":"Int J Pharm"},{"key":"1711_CR48","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0378-5173(96)04822-3","volume":"148","author":"C Roberta","year":"1997","unstructured":"Roberta C, Otto C, Maria EC, Michele T, Carmela S, Maria RG. Sterilization and freeze-drying of drug-free and drug loaded solid lipid nanoparticles. Int J Pharm. 1997;148:47\u201354.","journal-title":"Int J Pharm"},{"key":"1711_CR49","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.ijbiomac.2018.02.041","volume":"112","author":"C Pi","year":"2018","unstructured":"Pi C, Feng T, Liang J, Zhan CL, Wei YM, Zhao. Polymer blends used to develop felodipine-loaded hollow microspheres for improved oral bioavailability. Int J Biol Macromol. 2018;112:1038\u201347.","journal-title":"Int J Biol Macromol"},{"key":"1711_CR50","doi-asserted-by":"crossref","first-page":"3769","DOI":"10.2147\/IJN.S51578","volume":"8","author":"L Zhao","year":"2013","unstructured":"Zhao L, Wei Y, Huang Y, He B, Zhou Y, Fu J. Nanoemulsion improves the oral bioavailability of baicalin in rats: in vitro and in vivo evaluation. Int J Nanomedicine. 2013;8:3769\u201379.","journal-title":"Int J Nanomedicine"},{"issue":"5 Suppl","key":"1711_CR51","first-page":"1615","volume":"27","author":"S Yang","year":"2014","unstructured":"Yang S, Li K. Dissolution profile study on the novel doxycycline hydrochloride sustained-release capsules. Pak J Pharm Sci. 2014;27(5 Suppl):1615\u201320.","journal-title":"Pak J Pharm Sci"},{"issue":"5","key":"1711_CR52","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.nano.2011.08.016","volume":"8","author":"Z Zhang","year":"2012","unstructured":"Zhang Z, Gao F, Bu H, Xiao J, Li Y. Solid lipid nanoparticles loading candesartan cilexetil enhance oral bioavailability: in vitro characteristics and absorption mechanism in rats. Nanomedicine. 2012;8(5):740\u20137.","journal-title":"Nanomedicine."},{"issue":"6","key":"1711_CR53","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.addr.2007.09.007","volume":"60","author":"NL Trevaskis","year":"2008","unstructured":"Trevaskis NL, Charman WN, Porter CJ. Lipid-based delivery systems and intestinal lymphatic drug transport: a mechanistic update. Adv Drug Deliv Rev. 2008;60(6):702\u201316.","journal-title":"Adv Drug Deliv Rev"},{"issue":"11","key":"1711_CR54","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1517\/17425247.2011.604311","volume":"8","author":"H Harde","year":"2011","unstructured":"Harde H, Das M, Jain S. Solid lipid nanoparticles: an oral bioavailability enhancer vehicle. Expert Opin Drug Deliv. 2011;8(11):1407\u201324.","journal-title":"Expert Opin Drug Deliv"},{"key":"1711_CR55","doi-asserted-by":"crossref","first-page":"161","DOI":"10.7897\/2230-8407.04831","volume":"4","author":"RN Reddy","year":"2013","unstructured":"Reddy RN, Shariff A. Solid lipid nanoparticles: an advanced drug delivery system. Int J Pharm Sci Rev Res. 2013;4:161\u201371.","journal-title":"Int J Pharm Sci Rev Res"},{"issue":"3","key":"1711_CR56","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3109\/02652048.2016.1144819","volume":"33","author":"RR Patel","year":"2016","unstructured":"Patel RR, Chaurasia S, Khan G, Chaubey P, Kumar N, Mishra B. Highly water-soluble mast cell stabiliser-encapsulated solid lipid nanoparticles with enhanced oral bioavailability. J Microencapsul. 2016;33(3):209\u201320.","journal-title":"J Microencapsul"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-020-01711-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12249-020-01711-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-020-01711-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,11]],"date-time":"2021-06-11T00:02:26Z","timestamp":1623369746000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12249-020-01711-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,11]]},"references-count":56,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["1711"],"URL":"https:\/\/doi.org\/10.1208\/s12249-020-01711-2","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,11]]},"assertion":[{"value":"11 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflicts of interest in this work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The animal studies were approved by the Committee on the Ethics of Animal Experiments of the Southwest Medical University (No 2015DW040).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}],"article-number":"170"}}